| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0036 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate |
1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f14dc584acdbe5df40ab30164e6351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342add1f1519c331ca3ac3f38d6baa16 |
| publicationDate |
1998-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2289837-A1 |
| titleOfInvention |
Method and apparatus for targeted drug delivery into a living patient using magnetic resonance imaging |
| abstract |
The invention is an apparatus and method for targeted drug delivery into a living patient using magnetic resonance (MR) imaging. The apparatus and method are useful in delivery to all types of living tissue and uses MR Imaging to track the location of drug delivery and estimating the rate of drug delivery. An MR-visible drug delivery device positioned at a target site (e.g., intracranial delivery) delivers a diagnostic or therapeutic drug solution into the tissue (e.g., the brain). The spatial distribution kinetics of the injected or infused drug agent are monitored quantitatively and non-invasively using water proton directional diffusion MR imaging to establish the efficacy of drug delivery at a targeted location. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298043-B2 |
| priorityDate |
1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |